The binding properties and the activation of adenylate cyclase by the structural analogues of neurohypophysial hormones in the rat kidney membrane system were investigated. Certain structural modifications of the vasopressin molecule, i.e, absence of the primary amino group. removal of the carboxy-terminal part and combinations of the mcdifications lowered the affinity and activating properties of the compounds. A similar effect was observed in the oxytocin series where the absence of the primary amino group decreased the binding and activation of the adenylate cyclase. Two modifications improved the binding affinity: the carba substitution in both the series of deamino-analcgues and the introduction of a lipophilic substituent in the para~position of the aromatic amino acid in position 2 of the peptide chain. An attempt was made to correlate the binding and activating properties with the biolr-gical effects.
Tritiated [Sclysinelvasopressin eH-LVP) was prepared according to a described procedure-". The labelled peptide was purified by affinity chromatography using neurophysin bound to Sopharose 4B (ref. 27 ). Its specific radioactivity was 8·1 Ci/mmol (3'14.10 11 Beq/mmol). The biological activity determined in the rat vasopressor assay28 and pig 29 and rat 3 0 adenylatc cyclase systems was identical with that of the unlabelled material.
Neutral aluminium oxide was obtained from Woelm (Eschewege), Dowex AG 50 X 8 from Biorad Lab: sodium dodecyl sulfate from Serlabo, bovine serum albumin fraction (BSA) from Pentex, Tris, ATP (disodium salt) from Sigma Chern. Comp., cyclic AMP, creatine kinase and phosphocreatine (disodium salt) from Boehringer, EDTA, ouabain and sodium azide from Merck. 3H_cyclic AMP (21 Ci/mmol) from Commisariat a I'Energie Atomique, Saclay, a_ 32p_ -ATP (20 Ci/mmol) from New England Nuclear.
Methods
The membrane fraction was prepared from the medullary portions of Wistar rat kidney, according to the described procedure-,5. Adenylate cyclase activity was measured by the rate of conversion of a_ 32P_ATP to labelJed cyclic AMP (ref."). The incubation medium (l00 III final volume) contained Tris-Hfll 100 umol l"! pH 7'4, cyclic AMP 1 mmoIl-1 , MgCI., 75 mmoll-1, creatine phosphate 20 mmoll-1 , creatine kinase 100 ug per tube (l mgjml), ouabain 0·1 mmol l " ", sodium azide 10 mmot t" ", EDTA 0·25 mmoll-1• BSA 0·25 mgjml and various amounts of [8-lysine] vasopressin or its analogues. Membranes (40-60 ug of protein) were prcincubated for 15 min at 30 D e in the medium described above. The reaction was initiated by the addition of the substrate ATP (resulting concentration 0·25 mmol l t " ) and a~32P_ATP 'Ofabout 0·65 Ilei, the reaction proceeded for 6 min at 30"C and was stopped by the addition of sodium dodecyl sulfate (2% final concentration). Labelled cyclic AMP was separated by the method of Salomon and coworkcrs'[! with minor modifications. Cyclic AMP recovery was monitored using 3H cyclic AMP added immediately after stopping the reaction. The dose dependence for adcnylatc cyclase activation by vasopressin and analogues was characterized by K nct (concentration of peptide leading to half maximal activation", Hill coefficient (11) and by V max = AmnxIAmnxLvP~~' where A max is the maximal increase in enzyme activity over basal value. Binding assay. Binding of 3H_LVP was measured under experimental conditions identical with those used for the adenylate cyclase assay, except for the absence 11_ 3 2 p_ATP in the incubation medium. After 15 min incubation of membranes in the presence of 3 [8-lysine] vasopressin (5 Ilmoles I-I) were 94 ± 13 and 406 ± 52 picomoles of cyclic AMP (6 min) mg protein respect. (6 experiments). K.,t = 4·8 ± 0·5 nanomolcs .
.1-1 (9 experiments). The Hill coefficient for adenylatc cyclase activation was 0·86 ± 0'04 (mean ± SE, 6 experiments). Such a system was used for studying the effect of structural modifications of a series of synthetic analogues of vasopressin and oxytocin. In the vasopressin series, the absence of the primary amino group, carba substitution, aminoacylation of the amino-terminal part, elimination of the carboxy-terminal glycinamide and introduction of bulky atoms in the aromatic moiety of tyrosine were the structural features whose effect on the binding and adenylate cyclase activation was studied. In the oxytocin series. the effect was studied of the absence of the primary amino group. different carba modifications, and substitution of the amino acid in position 2 and 4 of oxytocin and its carba analogues. The results are summarized in Table I and II.
The absence of the primary amino group of vasopressin or its acylation with a short peptide chain lowered the affinity to the receptor and the activation of adeny- late cyclase (Fig. 1) , whereas the replacement of the disnlfide bond by the I-monc carba bridge had no effect on the binding and only slightly decreased the affinit for the enzyme system as compared with [8-arginine] deamino-vasopressin. The elimi nation/of the carboxy terminal glycinamide pronouncedly decreased the bindin and activating properties of the analogues studied. Introduction of one or two iodin atoms in the ortho position of tyrosine sharply decreased the affinity to both th systems on the average by three orders of ten (Fig. 2) . In the series of deamini vasopressin analogues negative cooperativity was observed.
In the oxytocin series, the absence of the primary amino group was without effec on the binding, while the character of carba bridge played a role in the magnitud. of binding (Fig. 3) . The 6-carba analogue had the same affinity as oxytocin, the othe two, I-carba and di-carba, had less than 10% of the affinity of deamino-oxytocir for binding. The di-carba substitution finds the same expression in activation of ade nylate cyclase. Both the mono-carba analogues of oxytocin had similar activatior properties as oxytocin.
Several analogues of deamino-ri-carba-oxytocin with modifications in position; were studied (Fig. 4) . The elimination of the hydroxy group (2-phenylalanine deriva tive) decreased the activation by one order often; no change was found when methy or ethyl group was introduced instead of hydroxyl. Substitution of the hydroxy by ethoxy group decreased the affinity for binding by one order of ten and the activating properties by two orders. A very similar modification, the replacement of the hydroxy by methoxy group in deamino-l-carba-oxytocin did not affect the binding and activating properties. Finally, the introduction of amino or nitro groups had small effect on the binding and activating properties when compared with [2-phenylalanine]deamino-6-carba-oxytocin. Two replacements of the amino acid in position 4 were stndied: replacement of glntamine by lipophilic isoleucine or by glutamic acid. The binding properties of the 4-isoleucine derivative were diminished by one order of ten whereas the activating properties were lowered by two orders of ten. The appearance of the free carboxyl in position 4 significantly depressed both the binding and activating properties.
DISCUSSION
Ample pharmacological data concerning the antidiuretic potencies of analogues of neurohypophysial hormones have already been obtained in experiments with rats. The rat kidney medullary membrane system has been proved to be well suited for investigating the structure-activity relationship of vasopressin analogues at the molecular level. This study was undertaken in order to obtain more detailed information on the structure-activity relationship, to gain knowledge of the consequences of the modification of molecular structure and finally to characterize several groups of analogues which have an altered specificity of biological action.
So far, two important features of the structure and resulting biological activity have been examined. For the analogues derived from [8-L-arginine]deamino-vasopressin (carba substitution in position 6 and alteration of amino acid in position 8), known as very potent antidiuretic agents, no higher affinity of V mox of activation was proved. Their prolonged antidiuretic action is probably due to changed distribution and metabolic stability as has already been proposed 4 ,34 -37 . Several analogues of oxytocin and vasopressin which may be structurally characterized by alterations performed in the amino-terminal part -modification of position I and 2 -were found to inhibit the adenylate cyclase activation by [8-lysine]-vasopressin (ref.
4 .' 8 ) . All had low, antidiuretic activity4 ,37 ,'9.40. When they were applied in subthreshold doses to anesthetized rats?", no clear inhibitory effect on the antidiuretic action of oxytocin or vasopressin was observed. Some of the analogues studied are characterized by the absence of primary amino group. [8-Arginine]deamino-vasopressin and [8-lysine]deamino-vasopressin had lower affinity and activating properties than the natural hormones. Deamino-oxytocin was a weaker activator of adenylate cyclase than oxytocin. The carba substitution in the cyclic part of the molecule is one of the favorable structural modifications which promotes greater metabolic stability of the molecule and provides some molecules even with a higher intrinsic activity.
[8-Arginine]deamino-6-carba-vasopressin was already studied in the rat kidney medullary membrane system'. Here we present the resnlts obtained with I-carba derivative. A certain preference of the receptor for 6-carba modification can be seen comparing the data on activation. Antidiuretically superactive vasopressin analognes were obtained by deamination in position I and stereoplacement in position 8 [8-arginine] vasopressin. Contrary to our expectation, when the 6-carba modification known to produce analogues with prolonged antidiuretic actiorr" was introduced into the molecule of [8-D-arginine]deamino-vasopressin, the activating properties of the resnltant analogue decreased", The presence of carboxy terminal glycinamide in vasopressin analogue is known to be necessary for their biological activity (with the exception of the activity on the CNS). It was therefore not surprising that its absence was accompanied by a snbstantialloss of affinity and activating properties: the desglycinamide derivative of N'-glycyl-glycyl-glycyljfi-Iysine]vasopressin is practically devoid of binding and activating properties. Two analogues oftriglycyl [8-lysine] vasopressin with modifications in position 8, 7 and 9 were studied. The data obtained with carba analogues" indicated that the activating properties decreased when arginine was replaced by ornithine. These results indicate that the recognition system of the receptor might distinguish the position of amino group in the side chain of the basic amino acid. A decrease of affinity and activating properties was observed when this group was shifted nearer to the backbone of the peptide molecule. The ability of triglycyl[7-glycine, 8-ornithine]vasopressin, which is not included in the Tables to compete with 3H_LVP for binding did not differ significantly from the binding properties of two other hormonogens.
In the oxytocin series both the deamination and l-carba and 6-carba substitution enhanced the antidiuretic potency of the analogues"? as compared with oxytocin. The higher antidiuretic potency, espeeially that of deamino-6-carba-oxytocin, eould not be attributed only to stronger binding and activation properties in the kidney receptor system. No prolonged antidiuretic activity was observed in the case of the monocarba derivatives of oxytocin.". Deamino-dicarba-oxytocin also had the same antidiuretic potency as oxytocin, but ten times lower binding and activating properties and no indication of prolonged antidiuretic activity.
Our studies concerning processes occurring at the molecular level in the kidney did not provide an explanation of the unexpectedly high antidiuretic response of carba analogues of oxytocin.
A series of deamino-6-carba-oxytocin derivatives that had higher natriuretic potency''? was stndied. The replacement of the tyrosine hydroxyl by methyl or ethyl group did not influence the natriuretic properties, while its elimination or substitution by ethoxy, amino or nitro group significantly lowered the natriuretic activity. The same holds for the binding and activating properties in the kidney receptor system. Both the analogues with the alkyl in place of the hydroxy group have the same or better ability than oxytocin or deamino-ti-carba-oxytocin to interact with the receptor.
The methylation of the tyrosine hydroxyl ([2-0-methyltyrosine]d<amino-l-carba--oxytocin) led to a decrease of the Am" (the maximum rate of cAMP production induced by [8-lysine] vasopressin) to 77%. The introduction of the ethoxy group caused a drop to 33% of Am,, ' The previously reported data' also give evidence of the importance of this kind of modification; nevertheless, the character and bulkiness of the groups used for modifying the amino acid in position 1 must also be taken into consideration.
While the substitution of the hydroxyl in position 2 of deamino-e-carba-oxytocin by either ethyl or methyl group had no effect on the binding and activating properties, the replacement of the tyrosine hydroxyl of oxytocin by ethyl group reduced binding and activation ten times. The presence of a free carboxyl in side chain of the amino acid residue in position 4 practically eliminated the interaction of the compound with the kidney receptor. Our results showed that carba substitution affected the binding and activating properties of resnlting oxytocin and vasopressin analogues in the same way. This was not so in the case of other modifications (substitutions in positions :2 and 4) when the binding and activating properties were dependent on the already performed substitutions in the primary structure ofthe peptide.
